Eric Lefkofsky looks to apply artificial intelligence to vast human genome

The debate between whether or not nature or nurture are the predominant factors in the creation of living beings has gone back all the way to the Greeks. Over the last 200 years, much progress has been made in the scientific understanding of the forces that underlie both nature and nurture and how those relate to the manifestation of living beings. However, there still remains a great deal of debate as to which factors contribute most to certain characteristics and behavioral traits of animals and people and learn more about Eric.

In the last 20 years, the debate between whether nature or nurture is a predominant factor in shaping the characteristics and behaviors of people has been largely skewing towards the nature side of the debate. Scientific papers, published in technical journals and mostly read by scientists themselves, have increasingly been skewed to the conclusion that the view of genetic determinists is largely proving to be the most accurate way to explain the world.

While this conclusion is deeply disturbing to some, particularly those espousing blank slatest philosophies, it also opens the possibility for incredible new treatments in medicine. One of the ways in which the reality of genetic determinism will definitely shape the future of medicine is through the ability of almost any individual to cheaply sequence their entire genome and more information click here.

Back in 2003, when the first full human genome was sequenced, the cost of doing so was more than $100 million. By 2017, that cost had dropped to just $5,000, an incredible example of exponentially decaying price. By 2025, it is estimated that the price of sequencing a full human genome will be less than $100 per person and Eric’s lacrosse camp.

Eric Lefkofsky, one of the nation’s leading medical philanthropists, is seeking to harness the power of having all individual genetic data accounted for. Because of the fact that genetics largely determines almost all medical outcomes, Lefkofsky believes that, through the use of such cutting-edge technologies as artificial intelligence, the widespread availability of individuals’ genomic data will usher in an age of precision medicine that will far eclipse anything seen up to the present.

Other Reference: